BEACOPP (escalated) Regimen for Hodgkin Lymphoma

doi:10.1310/hpj4410-858

Verified recordOpen access

BEACOPP (escalated) Regimen for Hodgkin Lymphoma

Hospital Pharmacy2009doi:10.1310/hpj4410-858

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Authors

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

BEACOPP (baseline) Regimen for Hodgkin Lymphoma

2009 · 0 citations

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

10.1007/bf01697624

10.1023/a:1008294312741

10.1200/jco.1998.16.12.3810

10.1093/annonc/9.suppl_5.s67

10.1023/a:1008301225839

10.1056/nejmoa022473

10.1093/annonc/mdg408

10.1093/annonc/mdi023

10.1080/10428190600688313

10.1016/j.ijrobp.2007.04.035

10.1016/j.ijrobp.2007.04.035 · 2007

10.1200/jco.2008.17.0910

10.1182/blood-2006-04-019901

BEACOPP (escalated) Regimen for Hodgkin Lymphoma

Referenced works

Cited by

External reference records

Additional external references